rs964184
|
|
Metabolic Syndrome X
|
G |
0.810 |
GeneticVariation
|
GWASCAT |
A previously known lipid locus, APOA1/C3/A4/A5 gene cluster region (SNP rs964184), was associated with MetS in all 4 study samples (P=7.23×10(-9) in meta-analysis).
|
22399527 |
2012 |
rs964184
|
|
Metabolic Syndrome X
|
G |
0.810 |
GeneticVariation
|
GWASDB |
A previously known lipid locus, APOA1/C3/A4/A5 gene cluster region (SNP rs964184), was associated with MetS in all 4 study samples (P=7.23×10(-9) in meta-analysis).
|
22399527 |
2012 |
rs964184
|
|
Metabolic Syndrome X
|
|
0.810 |
GeneticVariation
|
BEFREE |
A previously known lipid locus, APOA1/C3/A4/A5 gene cluster region (SNP rs964184), was associated with MetS in all 4 study samples (P=7.23×10(-9) in meta-analysis).
|
22399527 |
2012 |
rs12286037
|
|
Metabolic Syndrome X
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.
|
21386085 |
2011 |
rs12286037
|
|
Metabolic Syndrome X
|
C |
0.800 |
GeneticVariation
|
GWASDB |
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.
|
21386085 |
2011 |
rs2075290
|
|
Metabolic Syndrome X
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.
|
21386085 |
2011 |
rs2075290
|
|
Metabolic Syndrome X
|
C |
0.800 |
GeneticVariation
|
GWASDB |
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.
|
21386085 |
2011 |
rs2266788
|
|
Metabolic Syndrome X
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.
|
21386085 |
2011 |
rs2266788
|
|
Metabolic Syndrome X
|
C |
0.800 |
GeneticVariation
|
GWASDB |
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.
|
21386085 |
2011 |
rs2266788
|
|
Metabolic Syndrome X
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.
|
21386085 |
2011 |
rs2075291
|
|
Metabolic Syndrome X
|
A |
0.720 |
GeneticVariation
|
GWASCAT |
Identification of female-specific genetic variants for metabolic syndrome and its component traits to improve the prediction of metabolic syndrome in females.
|
31170924 |
2019 |
rs2075291
|
|
Metabolic Syndrome X
|
|
0.720 |
GeneticVariation
|
BEFREE |
It seems that APOA5 rs2075291 could play an important role in triglyceride and HDL-C level in metabolic syndrome affected, while the association of APOA5 rs662799 polymorphism is still under debate.
|
26702748 |
2016 |
rs2075291
|
|
Metabolic Syndrome X
|
|
0.720 |
GeneticVariation
|
BEFREE |
The chi(2) test and subsequent multivariate logistic regression analysis with adjustment for age, sex and smoking status found that the-3A-->G and 553G-->T (Gly185Cys) polymorphisms of APOA5, the 2052T-->C (Val653Val) and 1866C-->T (Asn591Asn) polymorphisms of LDLR, the 13989A-->G (Ile118Val) polymorphism of CYP3A4 and the 1014T-->A polymorphism of C1QTNF5 were significantly (false discovery rate <0.05) associated with the prevalence of metabolic syndrome, with the variant alleles of APOA5 and C1QTNF5 representing risk factors for and those of LDLR and CYP3A4 being protective against this condition.
|
17766366 |
2008 |
rs6589566
|
|
Metabolic Syndrome X
|
|
0.710 |
GeneticVariation
|
GWASCAT |
Multiple genotype-phenotype association study reveals intronic variant pair on SIDT2 associated with metabolic syndrome in a Korean population.
|
30382898 |
2018 |
rs6589566
|
|
Metabolic Syndrome X
|
|
0.710 |
GeneticVariation
|
BEFREE |
The effects of three constructed haplotypes (TAA, CGG, and CGA, in the order of rs662799, rs651821, and rs6589566) on the TG:HDL-C ratio and MS were estimated using multiple regression analyses in 2,949 Koreans and in each gender separately (1,082 men and 1,867 women).
|
24618354 |
2014 |
rs603446
|
|
Metabolic Syndrome X
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Multiple genotype-phenotype association study reveals intronic variant pair on SIDT2 associated with metabolic syndrome in a Korean population.
|
30382898 |
2018 |
rs121917821
|
|
Metabolic Syndrome X
|
|
0.010 |
GeneticVariation
|
BEFREE |
The apolipoprotein A5 Q139X, lipoprotein lipase (LPL) Hinf I, human paraoxonase 1 (PON1) 192Arg/Gln, cholesteryl ester transfer protein (CETP) Taq1B, adiponectin 45T>G and leptin (LEP) 25CAG were genotyped by real-time polymerase chain reaction in participants with and without MetS.
|
30381540 |
2018 |
rs2160669
|
|
Metabolic Syndrome X
|
|
0.010 |
GeneticVariation
|
BEFREE |
Four genetic variants (APOA5_rs651821, EFCAB4B_rs4766165, ZNF259_rs2160669 and APOBEC1_rs10845640) were selected because they increased MetS risk after adjusting for covariates.
|
31544728 |
2019 |
rs7118999
|
|
Metabolic Syndrome X
|
|
0.010 |
GeneticVariation
|
BEFREE |
We explored the association between two novel single nucleotide polymorphism (SNPs) of BUD13 (rs7118999 and rs10488698) and MetS and its complements.
|
28659142 |
2017 |